Summary data for 53 patients who underwent percutaneous sacroplasty
| Characteristics | Data |
|---|---|
| Total patients | 53 |
| Age (mean) (yr) | 76.4 ± 2.8 |
| Age younger than 70 yr | 13 (25%) |
| Age 70–79 yr | 20 (38%) |
| Age 80–89 yr | 15 (28%) |
| Age 90 yr or older | 5 (9%) |
| Female | 44 (83%) |
| Female/male ratio | 5:1 |
| Cancer-related fracture | 29 (55%) |
| Breast cancer | 9/29 (31%) |
| Multiple myeloma | 7/29 (24%) |
| Colorectal cancer | 6/29 (21%) |
| Small cell lung cancer | 2/29 (7%) |
| Prostate cancer | 1/29 (3%) |
| Melanoma | 1/29 (3%) |
| Cervical cancer | 1/29 (3%) |
| Hematologic malignancy | 1/29 (3%) |
| Pancreatic cancer | 1/29 (3%) |
| Osteoporotic fracture | 16 (30%) |
| Traumatic fracture | 8 (15%) |
| Bilateral fractures treated | 44 (83%) |
| Sacroplasty with conscious sedation | 39 (74%) |
| Sacroplasty under general anesthesia | 14 (26%) |
| Sacroplasty with CT guidance | 48 (91%) |
| Sacroplasty with fluoroscopic guidance | 5 (9%) |
| Significant complications | 0 |
| Procedural mortality | 0 |
| Time to follow-up (days) | 27 (±3.7) |